TNFAIP3 and allergic asthma: They found that vaccinated mice showed significantly reduced serum OVA-specific IgE levels, alleviated local inflammatory cell infiltration, and increased regulatory T (Treg) cells numbers in the lungs (23), indicating that A20 might be a potential treatment target for allergic asthma (Figure 1B).